Breast Cancer

Perindopril, Bisoprolol Not Effective for Preventing Trastuzumab-mediated Left Ventricular Remodeling

Perindopril, Bisoprolol Not Effective for Preventing Trastuzumab-mediated Left Ventricular Remodeling

By

Perindopril, an angiotensin-converting enzyme (ACE) inhibitor, and the beta blocker bisoprolol protected against trastuzumab-related declines.

Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

By

Loss of bone density related to chemotherapy and adjuvant therapy for breast cancer can lead to debilitating hip and vertebral fractures. This discussion discusses the impact of resistance training for these patients.

Depression May Contribute to Receipt of Inappropriate Breast Cancer Treatment

Depression May Contribute to Receipt of Inappropriate Breast Cancer Treatment

By

An analysis of data from Danish women with early-stage breast cancer assessed women's risk of receiving nonguideline treatment for their disease if they had a prior diagnosis of depression or prior treatment with antidepressants.

Vaginal Ring/Cream May Be Feasible for Urogenital Atrophy

Vaginal Ring/Cream May Be Feasible for Urogenital Atrophy

The feasibility of an estradiol-releasing vaginal ring vs intravaginal testosterone cream for women with HR-positive stage I to III breast cancer using aromatase inhibitors who reported vaginal dryness, decreased libido, or dyspareunia is evaluated in a phase 2 study.

Hospital Volume Linked to Odds of Appropriate Breast Cancer Locoregional Treatment

Hospital Volume Linked to Odds of Appropriate Breast Cancer Locoregional Treatment

By

Investigators examined the extent to which hospital volume explains variations in diagnosis and treatment of breast cancer.

Higher Protein Intake May Modestly Improve Breast Cancer Survival

Higher Protein Intake May Modestly Improve Breast Cancer Survival

By

An analysis of data from women with stage I to III breast cancer investigated the potential association between protein intake and survival.

Economic Burden Related to Chemotherapy-related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System

Economic Burden Related to Chemotherapy-related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System

[Breast Cancer: Targets and Therapy] This research evaluates costs related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care delivery system.

Telerehabilitation Program Improves Posttreatment Effects in Breast Cancer Survivors

Telerehabilitation Program Improves Posttreatment Effects in Breast Cancer Survivors

By

Study evaluates whether a web-based rehabilitation program can effectively improve pain, fatigue, strength, and quality of life for breast cancer survivors.

Both Older and Younger Women Benefit From Breast Reconstruction

Both Older and Younger Women Benefit From Breast Reconstruction

No greater risk of complications for older patients; benefited as much as younger breast cancer patients

Prolactin Expression May Indicate Better Prognosis for Patients With TNBC

Prolactin Expression May Indicate Better Prognosis for Patients With TNBC

By

Expression of this hormone receptor may indicate a less aggressive subtype of triple-negative breast cancer and better prognosis for patients with the disease.

Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows

Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows

By

A data analysis reveals the likelihood of older women with to ER-positive DCIS to initiate and adhere to adjuvant tamoxifen or aromatase inhibitors.

Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors

Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors

By

In this study, researchers assessed data on women who underwent breast cancer treatment to identify the factors associated with posttreatment imaging use.

Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer

Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer

By

The recurrence score assay stratifies early stage, estrogen receptor-positive breast cancer by recurrence risk. This study assessed how clinicians use the recurrence score to recommend adjuvant systemic therapy or patients' experiences with testing decision-making.

Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors

Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors

By

Researchers examined the long-term effects of a short-term culturally based dietary intervention on increasing the consumption of fruits and vegetables, decreasing fat, and changing biomarkers associated with recurrence in Hispanic breast cancer survivors.

How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians

How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians

By

Cancers that cause more readily noticeable physical changes can produce self-image challenges for patients. This discussion reviews what interventions can help validate patients' self-image concerns.

Costs of Breast Cancer Chemotherapy Vary Widely in the United States

Costs of Breast Cancer Chemotherapy Vary Widely in the United States

Researchers found wide variances in the cost of breast cancer chemotherapy, depending on the course of treatment selected.

Study Confirms Long-term Risk of VTE in Patients With Breast Cancer

Study Confirms Long-term Risk of VTE in Patients With Breast Cancer

By

Patients with breast cancer have more than 2 times the risk for developing a venous thromboembolism 5 years after diagnosis compared with the general population.

CDK4/6 Inhibitor Plus Aromatase Inhibitor Improves Progression-Free Survival in Metastatic Breast Cancer

CDK4/6 Inhibitor Plus Aromatase Inhibitor Improves Progression-Free Survival in Metastatic Breast Cancer

By

Adding ribociclib to letrozole significantly improves progression-free survival for postmenopausal women with metastatic hormone receptor (HR)-positive breast cancer, compared with hormone therapy alone.

Expectations of Chemotherapy Side Effects Influence Patients' Experiences During Breast Cancer Treatment

Expectations of Chemotherapy Side Effects Influence Patients' Experiences During Breast Cancer Treatment

By

Recent studies indicate that adverse side effects can result from factors unrelated to the pharmacologic agent, but rather from other factors.

Most Women Newly Diagnosed With Breast Cancer Perceive High PCP Quality

Most Women Newly Diagnosed With Breast Cancer Perceive High PCP Quality

Overall, 66.2 and 69.1 percent of women perceive high PCP engagement and communication

Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study

Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study

[Clinical Medicine Insights: Oncology] A case study of a 49-year-old premenopausal woman with metastatic invasive ductal breast carcinoma in the vertebral and iliac bones, which progressed with new metastases to her hips, thigh bones, and vertebrae.

G-CSF May Only Modestly Prevent Neutropenia-related Hospitalization

G-CSF May Only Modestly Prevent Neutropenia-related Hospitalization

By

Primary prophylaxis with granulocyte colony-stimulating factor provided only a low-to-modest benefit in reducing neutropenia-related hospitalization in patients with breast cancer receiving low-to-intermediate risk chemotherapy regimens.

Risk of Endometrial Abnormalities With Adjuvant Tamoxifen for Early Stage Breast Cancer Is Low

Risk of Endometrial Abnormalities With Adjuvant Tamoxifen for Early Stage Breast Cancer Is Low

By

For women receiving tamoxifen in the adjuvant setting for early stage breast cancer or as a preventive for high risk of breast cancer, the risk of developing endometrial pathology in those with negative uterine examination findings prior to treatment is very low.

Affordable Care Act Tied to Increased Breast Cancer Care Access for Hispanics

Affordable Care Act Tied to Increased Breast Cancer Care Access for Hispanics

Following the release of the Affordable Care Act (ACA) an increase in Hispanic women receiving breast cancer treatment and their related participation in clinical trials was observed.

Patients Receiving RT in APBI Facilities Despite Eligibility for Observation

Patients Receiving RT in APBI Facilities Despite Eligibility for Observation

By

Patients with early stage breast cancer who received breast-conserving surgery and were eligible for observation were more likely to undergo adjuvant radiotherapy in facilities performing APBI.

ASCO, ASTRO Issue Guideline Update for Postmastectomy RT

ASCO, ASTRO Issue Guideline Update for Postmastectomy RT

By

The American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology have issued a joint consensus guideline update for the use of radiotherapy following mastectomy in patients with breast cancer.

G-CSF Prophylaxis May Modestly Reduce Neutropenia-related Hospitalization

G-CSF Prophylaxis May Modestly Reduce Neutropenia-related Hospitalization

By

Primary prophylaxis with G-CSF may modestly reduce neutropenia-related hospitalization in patients with breast cancer receiving docetaxel and cyclophosphamide or docetaxel, carboplatin, and trastuzumab.

Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients

By

Bioimpedance spectroscopy (BIS) effectively assesses for subclinical breast cancer-related lymphedema in patients at risk, and accurately assess patients for response to treatment.

Chemotherapy-Induced Dormancy Improves Immunotherapy for Breast Cancer

Chemotherapy-Induced Dormancy Improves Immunotherapy for Breast Cancer

By

Inducing quiescent dormancy with conventional chemotherapy makes cancer cells more susceptible to immunotherapy, thereby minimizing potential for tumor recurrence.

Artificial Intelligence Method Improves Mammography Readings

Artificial Intelligence Method Improves Mammography Readings

By

Natural language processing (NLP) software correlated key characteristics expressed verbally in mammography reports with pathologic findings, providing an accurate indication for biopsy referral.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs